Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
3
self-reported 2–10 band
Founded
Not recorded
Legal entities
None matched
Office countries
1
1 address
Funding rounds
2
Seed · Jul 2020 · US$ 275.8K
Company type
Privately Held
self-reported
Description
Radetec Diagnostics is a Melbourne-based biotech start-up specialised in the manufacturing of advanced luminescent nanoparticles called “quantum dots”, which can be used as labels for imaging and sensing applications. Radetec is using its own quantum dots to develop two point-of-care tests based on lateral flow technology: a rapid multiplex test for Chlamydia and Gonorrhoea (the two most prevalent sexually transmitted infections worldwide) and a rapid antigen test for COVID-19. Radetec’s tests will allow users to test for these diseases accurately, inexpensively, quickly and conveniently — something that is considered the ‘holy grail’ of infectious disease diagnosis and prevention.
Capabilities:
- Production of advanced fluorescent nanoparticles (quantum dots). We can fine-tune the emission wavelength and the surface chemistry of the particles, making them soluble in water or in organic solvents, and modify them with organic or biological molecules to make them suitable for biomedical applications previously not possible to achieve.
- Production of scientific equipment for the development of lateral flow assays. Radetec has created its own striper (to draw lines of proteins on nitrocellulose sheets) and electronic reader (to measure fluorescence and colourimetric signals) that can be used for R&D. The basic models of the striper and the reader are a cost-effective way to develop lateral flow assays in-house.
Specialties
All 8 specialties
- Nanotechnology
- In-Vitro Diagnostics
- Quantum Dots
- Lateral flow assays
- R&D
- Medical devices
- Antibody
- POCT
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU710 Collins St; Docklands, Victoria 3008Primary
Grid intelligence Members
Funding
Last round · 16 July 2020US$ 275.8KSeed
Rounds2
Round typeSeed · venture round
Amount (USD)275,800
Stage rank2
Investors named0
Since last round5 yr 6 mo
Funding
Show as table · 2 funding rounds
| Rounds | 2 |
|---|---|
| Axis | 2021 to 2026 |
| Seed · 16 Jul 2020 | US$ 275.8K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
2 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
How many people work at Radetec Diagnostics?
3 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Radetec Diagnostics have offices?
One address on record, Australia only. Primary: 710 Collins St, Docklands, Victoria 3008.
Has Radetec Diagnostics raised funding?
Two rounds. Latest 16 July 2020: Seed, US$275,800.
What does Radetec Diagnostics list as its specialties?
Eight tags on the brand's own list, among them r&d, nanotechnology and medical devices.
Which companies are listed alongside Radetec Diagnostics?
1 profile lists Radetec Diagnostics as a peer — 43rd percentile in Medical Equipment Manufacturing. It lists ten peers of its own. XIA Infinite Solutions Pty Ltd lists it back.